Latest News of LRN
Acelyrin Inc (SLRN) Q3 2024 Earnings Call Highlights: Strategic Pipeline Refocus and Financial ...
By Yahoo! Finance |
1 week ago
Acelyrin Inc (NASDAQ:SLRN) is focused on developing Magua map for thyroid eye disease. Positive outcomes include promising proof of concept data, FDA alignment, and strong financial standing. Challeng...
Stride, Inc. (LRN): A Bull Case Theory
By Yahoo! Finance |
4 weeks ago
Stride, Inc. (LRN) is a key player in online education, with growing demand for flexible learning. The company serves K-12 students and adults across various segments. Despite revenue growth, challeng...
Stride Inc (LRN) Q1 2025 Earnings Call Highlights: Record Enrollments and Robust Financial ...
By Yahoo! Finance |
4 weeks ago
CEO James Rhyu discusses record enrollment driven by strong organic demand and low acquisition costs. He emphasizes the non-political nature of education and the company's focus on meeting diverse cus...
-
Is Stride, Inc. (LRN) a Good Buy Despite High Short Interest?
By Yahoo! Finance | 2 months agoInsider Monkey recently featured the 10 worst affordable stocks to buy now, analyzing Stride, Inc. among them. The article discussed the impact of macroeconomic conditions on Fed rate cuts, market flu...
-
Why Is Acelyrin, Inc. (SLRN) The Best New Penny Stock to Buy Now?
By Yahoo! Finance | 3 months agoAcelyrin, Inc. (NASDAQ:SLRN) is a promising biopharmaceutical company specializing in autoimmune disease treatments. Despite setbacks, recent trial successes and strong financials position SLRN as one...
-
Is Stride, Inc.'s (NYSE:LRN) Latest Stock Performance A Reflection Of Its Financial Health?
By Yahoo! Finance | 4 months agoStride's stock has surged 21% in the last three months, prompting an analysis of its Return on Equity (ROE). With an ROE of 17%, the company efficiently turns shareholder investments into profits....
-
Here's Why We're Watching Acelyrin's (NASDAQ:SLRN) Cash Burn Situation
By Yahoo! Finance | 4 months agoDespite losses, shareholders can profit by investing in a good business at the right price. Acelyrin's cash burn rate and runway are examined, revealing potential concerns despite its solid cash reser...
-
Here's Why We Think Stride (NYSE:LRN) Is Well Worth Watching
By Yahoo! Finance | 4 months agoInvesting in companies with potential turnaround stories is appealing, but risky. Focusing on profitable companies like Stride (NYSE:LRN) is a traditional strategy. Stride has shown strong EPS and rev...
-
Is Stride (LRN) Stock Outpacing Its Consumer Discretionary Peers This Year?
By Yahoo! Finance | 5 months agoK12 (LRN) is a top-performing stock in the Consumer Discretionary sector, boasting a Zacks Rank of #1 (Strong Buy) and a 14.4% year-to-date return, outperforming peers....